NCT01311011

Brief Summary

Phase II Prospective Study of the Clinical Efficacy of Autologous SCT in patients with Critical Limb Ischemia

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
26

participants targeted

Target at below P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2008

Completed
2.3 years until next milestone

First Submitted

Initial submission to the registry

March 6, 2011

Completed
3 days until next milestone

First Posted

Study publicly available on registry

March 9, 2011

Completed
Last Updated

December 13, 2011

Status Verified

December 1, 2011

First QC Date

March 6, 2011

Last Update Submit

December 11, 2011

Conditions

Critical Limb Ischemia

Keywords

Critical Limb Ischemia

Interventions

SCTPROCEDURE

SCT

Eligibility Criteria

Age14 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with Critical Limb Ischemia

You may qualify if:

  • Patients with Critical Limb Ischemia

You may not qualify if:

  • Patients with other than Critical Limb Ischemia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kfsh & Rc

Riyadh, Saudi Arabia

RECRUITING

MeSH Terms

Conditions

Chronic Limb-Threatening Ischemia

Condition Hierarchy (Ancestors)

Peripheral Arterial DiseaseAtherosclerosisArteriosclerosisArterial Occlusive DiseasesVascular DiseasesCardiovascular DiseasesPeripheral Vascular DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsIschemia

Study Officials

  • H Al-Zahrani, M.D.

    KFSH & RC

    PRINCIPAL INVESTIGATOR

Central Study Contacts

H Al-Zahrani, M.D.

CONTACT

+966-1-4423949

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 6, 2011

First Posted

March 9, 2011

Study Start

November 1, 2008

Last Updated

December 13, 2011

Record last verified: 2011-12

Locations

SA(1)